Abstract
INTRODUCTION
Interleukin-1β (IL-1β) is an important acute response factor of host defense against microbial infections and a key mediator of inflammation in multiple organs [1, 2] . Viral and bacterial pathogens trigger inflammasome formation and subsequent caspase-1 activation and IL-1β maturation [3] . IL-1β is synthesized as a biologically inactive 31 kDa pro-IL-1β polypeptide and must be post-translationally processed by caspase-1 to generate the mature 17 kDa pro-inflammatory cytokine IL-1β [4] . Overproduction of IL-1β is associated with multiple autoimmune diseases and septic shock and animals deficient in IL-1β are highly susceptible to microbial infections [5, 6] . Activated monocytes and macrophages rapidly release large amounts of mature IL-1β and inflammasome components including caspase-1 [7] ; macrophages deficient in caspase-1 expression have impaired processing of pro-IL-1β and undetectable IL-1β secretion [8] . This suggests that IL-1β release and caspase-1 activation are closely related events. Because most known inhibitors of IL-1β production block caspase-1 activation, previous studies are not able to determine whether caspase-1 activation/pro-IL-1β processing and IL-1β release are separate or linked processes. We have previously demonstrated that human defensin peptide human α-defensin-5 (HD-5) can block the release of IL-1β, but not tumor necrosis factor-α (TNF-α), from lipopolysaccharide (LPS)-activated human monocytes stimulated with Adenosine triphosphate (ATP) [9] . Here, using HD-5 as a molecular tool, we explored whether IL-1β release is an indivisible process from caspase-1 activation/pro-IL-1β processing in human monocytes.
MATERIALS AND METHODS

Human HD-5
Synthetic human defensin HD-5 was prepared by t-Boc solid-phase synthesis as described previously [9] . All peptides were folded and purified to homogeneity by reversed-phasehigh-performance liquid chromatography and their molecular weights verified by electrospray ionization mass spectrometry.
Peripheral blood monocyte isolation
Peripheral blood monocytes (PBMC) from healthy adult donors were prepared as described previously [9] . Briefly, blood was diluted with RPMI 1640, overlaid on lymphocyte separation medium (Mediatech), and centrifuged at 400 × g for 35 min. The mononuclear cell layer was washed with PBS and centrifuged at 250 × g for 10 min. The cells were then resuspended in 25 mL of PBS plus citrate solution and overlaid on Percoll (GE Healthcare) prediluted 9/1 with 1.5 mol/L NaCl. After a 35-min centrifugation at 400 × g, the PBMC were washed with PBS again. Cells were counted using trypan blue exclusion and cells were resuspended in monocyte medium [RPMI 1640, 5%FBS, 20 mmol/L HEPES (pH 7.3), 1%streptomycin/ penicillin] and incubated at 37 ℃ for 2 h to allow for adherence, after which medium supernatants were discarded. Attached cells were rinsed twice with monocyte medium and used immediately or incubated in monocyte medium overnight at 37 ℃ in a 5%CO2 environment.
IL-1β posttranslational processing and release assay
Fresh or overnight cultured PBMCs were treated with 20 ng/mL LPS for 2 h at 37 ℃. In some experiments, the media was removed then replaced with RPMI (without Met, Cys, or Glu), + 1% FBS + 25 mmol/L HEPES pH 7.4 + 300 mg/L Glutamine + 83 μCi/mL 35 S-Met/Cys and incubated at 37 ℃ for 1 h. Cells were then rinsed and media was replaced with RPMI (+ Glu). Adenosine triphosphate (ATP, 1 mmol/L), HD-5 (50 μg/mL), and/or nigericin (Nig, 30 μmol/L) was added to culture media and incubated at 37 ℃ for 1.5 h. The supernatants were collected, 1%Triton X-100 and protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, United States) added, then spun down. Cells were lysed in 500 μL lysis buffer (25 nmol/L HEPES pH 7.4 + 150 mmol/L NaCl + 0.1%Triton X-100 + Protease Inhibitor cocktail) then spun down. Cell lysates and supernatants were subject to IL-1β immunoprecipitation and western blot analysis of caspase-1 as described previously [9] . Results shown are a representative from three independent experiments.
Statistical analysis
All experiments were repeated 3 times to ensure reproducibility. Image J software (NIH) was used to quantitate protein bands. Proteins bands between two different treatment groups were considered statistically significant when P < 0.05, by t-test analysis.
RESULTS
HD-5 blocks the release of IL-1β from both freshly isolated and overnight cultured monocytes
Our previous studies have shown that HD-5 can block the release of pro-IL-1β and mature IL-1β from ATP stimulated human monocytes that were cultured overnight prior to LPS exposure [9] . Since culturing monocytes in vitro can lead to further differentiation into macrophagelike cells [10, 11] , we determined whether the subcultured monocytes behaved similarly to freshly isolated cells. As shown in Figure 1 (upper panel) the extracellular release of mature IL-1β from both freshly isolated and overnight cultured monocytes was blocked by HD-5. Interestingly, we also observed that freshly isolated monocytes had enhanced intracellular processing of pro-IL-1β to IL-1β ( Figure 1 , lower panel, lanes 1-2 vs 3-4) suggesting that increased time in culture can decrease the ability of monocytes to process IL-1β. Most importantly, it was found that the intracellular processing of pro-IL-1β to mature IL-1β was not inhibited by HD-5 as evidenced by the presence of intracellular mature IL-1β in cell lysates from monocytes treated with HD-5 ( Figure 1, lower panel) .
HD-5 treatment significantly blocks IL-1β release from monocytes stimulated with Nig
To determine whether the ability of HD-5 to block IL-1β release in overnight-cultured, LPS-activated monocytes was specific to ATP stimulation, we treated LPS-activated monocytes with ATP or Nig. Similar to ATP, Nig is a microbial toxin that acts as an inflammasome inducer, leading to caspase-1 maturation and IL-1β processing and release [12, 13] . We found that, similar to its effect on ATPmediated IL-1β release, HD-5 treatment was also able to significantly block IL-1β release from monocytes stimulated with Nig ( Figure 2, upper panel) . Furthermore, HD-5 did not block Nig-induced intracellular processing of pro-IL-1β to mature IL-1β as indicated by the presence of mature IL-1β in the cell lysate (Figure 2 , lower panel).
ATP and Nig-mediated caspase-1 activation and extracellular release from LPS-activated monocytes is not affected by HD-5
Caspase-1 activation has been implicated in both the processing and release of IL-1β [14, 15] . Because our current studies have shown that HD-5 selectively blocked the release but not the processing of pro-IL-1β to mature IL-1β, it is important to know whether HD-5 has any effect on caspase-1 activation and release. As shown in Figure 3 , ATP/Nig-mediated caspase-1 activation and extracellular release from LPS-activated monocytes were not affected by HD-5. This observation is consistent with the finding that HD-5 did not block the intracellular processing of pro-IL-1β to IL-1β (Figures 1 and 2) .
DISCUSSION
Current research suggests that once caspase-1 becomes active it leads to both the processing and release of IL-1β [16] [17] [18] . Although the processing and release of IL-1β are rapid and probably concurrent events, it has been suggested previously that the cleavage of pro-IL-1β and release of mature IL-1β are likely independent of each other [19] . However, this speculation remains hypothetical because, due to the technical limitations, the presence of mature IL-1β inside LPS-primed, ATP-stimulated monocytes have not been documented prior to this report. Here, under certain conditions we have clearly shown that IL-1β release but not its processing from pro-IL-1β by caspase-1 in ATP/Nig-stimulated monocytes can be blocked by HD-5. To our knowledge, this report provides the first direct evidence that the processing of pro-IL-1β to mature IL-1β and extracellular release of mature IL-1β are two divisible events in human monocytes. Our results also indicate that the majority of pro-IL-1β is processed intracellularly by activated caspase-1 in freshly isolated monocytes ( Figure 1A ). This observation is consistent with the report that human blood monocytes release processed IL-1β after a one-time stimulation with toll-like receptor 4 ligands due to the resulting constitutively activated caspase-1 [16] . Furthermore, because the release of IL-1β, but not the externalization of caspase-1 was affected by HD-5, our studies suggest that IL-1β seems to be released directly to the extracellular environment without the involvement of caspase-1 inflammasome.
The mechanisms by which pro-IL-1β and mature IL-1β are released from cytokine producing cells have been an intriguing and unsolved question of IL-1β biology for decades. Known activators of caspase-1 and IL-1β release include ATP, adjuvants, and various microbial molecules [20] . Using different experimental systems, studies on ATP-induced IL-1β maturation have posited four different and conflicting models of IL-1β secretion, including secretory lysosome exocytosis [21, 22] , microvesicle shedding [23] [24] [25] , direct transport across the plasma membrane [26] , and exocytosis of exosome-containing multivesicular bodies [7] . The multiple models of IL-1β secretion reflect the confusion in this area. It is true that although ATPinduced caspase-1 activation is followed by the processing of pro-IL-1β to IL-1β in the cytosol and secretion of IL-1β, other protein release mechanisms, such as externalization of caspase-1, secretory lysosomes and microvesicle shedding, do occur. However, externalization of caspase-1 and other inflammasome components, secretory lysosomes and microvesicle shedding may be cell-type specific processes after ATP stimulation and may not be involved in IL-1β secretion from monocytes. Here, we provide direct evidence that IL-1β secretion is a separable process from inflammasome activation/caspase-1 externalization and IL-1β processing in human monocytes. Inflammasome activation and caspase-1 activity are required but not sufficient for the release of IL-1β.
Taken together, our studies clearly demonstrated that intracellular processing of pro-IL-1β to mature IL-1β and the externalization of mature IL-1β are divisible events in human monocytes. Although the molecular mechanisms by which HD-5 blocks the release of mature IL-1β has yet to be revealed in future studies, a better understanding of IL-1β processing and release may lead to the discovery of novel molecular targets for IL-1β blockade and the development of new therapeutic approaches to treat life-threatening microbial infections and inflammatory diseases.
COMMENTS
Background
Interleukin-1β (IL-1β) is secreted by monocytes and macrophages and is an important acute response factor of host defense against microbial infections. IL-1β is synthesized as a biologically inactive 31 kDa pro-IL-1β polypeptide and must be post-translationally processed by caspase-1 to generate the mature 17 kDa IL-1β that is released into the extracellular space.
Research frontiers
Macrophages deficient in caspase-1 expression have undetectable IL-1β secretion. This suggests that IL-1β release and caspase-1 activation are closely related events. Because most known inhibitors of IL-1β production block caspase-1 activation, previous studies are not able to determine whether caspase-1 activation/pro-IL-1β processing and IL-1β release are separate or linked processes. This report shows that processing of pro-IL-1β by caspase-1 and the release of mature IL-1β from human monocytes are distinct and separable events.
Innovations and breakthroughs
Recent reports suggest IL-1β secretion involves the formation of the inflammasome, leading to the cleavage and activation of caspase-1, which in turn proteolytically processes pro-IL-1β. Biologically active IL-1β is subsequently secreted by the cell. Here authors propose that IL-1β secretion involves a more complex regulatory mechanism.
Applications
Standard therapy for patients with autoimmune diseases or lymphomas involves blocking IL-1β activity. By knowing how IL-1β is processed and released, this study may lead to the development of novel therapeutics that can block IL-1β release and prevent or enhance treatment for these debilitating proinflammatory disorders.
Terminology
The inflammasome is a multi-protein complex responsible for the activation of caspase-1, an enzyme that cleaves and activates downsteam targets such as IL-1β. IL-1β is a pro-inflammatory cytokine secreted by immune cells to aid in the defense of microbial infection. Human α-defensin 5 (HD-5) is an anti-microbial peptide that normally functions by binding to the microbial cell membrane to form a lethal pore. in the presence or absence of human α-defensin 5 (HD-5) (50 μg/mL) for 1.5 h. Media were harvested, precipitated, and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western blot analysis with anticaspase-1 p10 antibodies (1:1000) that recognize both the pro-caspase-1 (45 kDa) and cleaved caspase-1 p10 subunit proteins.
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